Enavogliflozin: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Enavogliflozin

• A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
  NCT06642623 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
  NCT05672836 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 31 locations
• Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation
  NCT06528262 · Phase: Phase 4 · Ages: 19 Years to 84 Years · Sex: All (male and female) · 1 location
• Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
  NCT06782139 · Phase: Phase 4 · Ages: 20 Years to 79 Years · Sex: All (male and female) · 1 location
• Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
  NCT06399835 · Phase: Phase 4 · Ages: 20 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Enavogliflozin?

5 recruiting trials across 9 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.